Literature DB >> 24267683

Equine melanocytic tumors.

Jeffrey C Phillips1, Luis M Lembcke.   

Abstract

Melanomas are among the most common skin tumors in horses, with prevalence rates reaching as high as 80% in adult gray horses. Most melanocytic tumors are benign at initial presentation; however, if left untreated, up to two-thirds can progress to overt malignant behavior. Standard local treatment options can be used to treat solitary early-stage lesions but do not address the underlying risk of recurrent tumor formation or the transformation to a malignant phenotype. An understanding of the specific molecular genetic factors associated with tumor formation should lead to targeted therapies that can be used to treat or ideally prevent disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Genetics; Horse; Immunotherapy; Melanoma; Treatment; Vaccine

Mesh:

Year:  2013        PMID: 24267683     DOI: 10.1016/j.cveq.2013.08.008

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  9 in total

1.  Primary sinonasal malignant melanoma with systemic metastasis in a non-gray horse.

Authors:  Hitoshi Hatai; Takashi Hatazoe; Haruka Seo; Teruaki Tozaki; Shingo Ishikawa; Noriaki Miyoshi; Kazuhiro Misumi; Seiji Hobo
Journal:  J Vet Diagn Invest       Date:  2020-12-08       Impact factor: 1.279

2.  Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth.

Authors:  Alexander J Lakhter; James Hamilton; Raymond L Konger; Nickolay Brustovetsky; Hal E Broxmeyer; Samisubbu R Naidu
Journal:  J Biol Chem       Date:  2016-08-18       Impact factor: 5.157

3.  Malignant rectal melanoma in 2 dogs.

Authors:  Lorelei L Clarke; Daniel R Rissi
Journal:  Can Vet J       Date:  2018-02       Impact factor: 1.008

4.  Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagent.

Authors:  Christiane L Schnabel; P Steinig; M Koy; H-J Schuberth; C Juhls; D Oswald; B Wittig; S Willenbrock; H Murua Escobar; C Pfarrer; B Wagner; P Jaehnig; A Moritz; K Feige; J-M V Cavalleri
Journal:  BMC Vet Res       Date:  2015-06-23       Impact factor: 2.741

Review 5.  Clinical trials of immunogene therapy for spontaneous tumors in companion animals.

Authors:  Gerardo Claudio Glikin; Liliana María Elena Finocchiaro
Journal:  ScientificWorldJournal       Date:  2014-11-17

6.  Rhabdoid melanoma in a harpy eagle (Harpia harpyja).

Authors:  César Augusto Pinzón-Osorio; Jersson Ávila-Coy; Arlen P Gomez; Diana Marcela Álvarez-Mira
Journal:  Vet Anim Sci       Date:  2021-06-06

7.  Preliminary Study: Proteomic Profiling Uncovers Potential Proteins for Biomonitoring Equine Melanocytic Neoplasm.

Authors:  Parichart Tesena; Amornthep Kingkaw; Wanwipa Vongsangnak; Surakiet Pitikarn; Narumon Phaonakrop; Sittiruk Roytrakul; Attawit Kovitvadhi
Journal:  Animals (Basel)       Date:  2021-06-27       Impact factor: 2.752

8.  Gross, histologic, and immunohistochemical characteristics of cutaneous chromatophoromas in captive bearded dragons.

Authors:  Colleen F Monahan; Anne Meyer; Michael M Garner; Matti Kiupel
Journal:  J Vet Diagn Invest       Date:  2021-07-02       Impact factor: 1.569

9.  In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.

Authors:  Lisa Annabel Weber; Anne Funtan; Reinhard Paschke; Julien Delarocque; Jutta Kalbitz; Jessica Meißner; Karsten Feige; Manfred Kietzmann; Jessika-Maximiliane V Cavalleri
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.